Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Ciaoon Oct 24, 2022 9:55am
108 Views
Post# 35043348

RE:"importance of macrophages in finding new treatments"

RE:"importance of macrophages in finding new treatments"There's the good and bad side of macrophages. Y-BG is showing potential to reduce the inflammatory response and the cytokine storm and this could be due to it's abilitiy to re-program the macrophages. Preventing, stopping, (and maybe even reversing early stage) fibrosis and inflammation (ongoing for long Covid patients) is what the CZO/McMaster research is all about. It's taking more time that most of us would have hoped, but solid pre-clinical studies are needed before moving to human trials.

Getting Y-BG as an immune booster to market, or as an eventual inhalable prophylatic / therapeutic needs to be accelerated given the worldwide health crisis. 
<< Previous
Bullboard Posts
Next >>